JP2004511237A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2004511237A5 JP2004511237A5 JP2002534565A JP2002534565A JP2004511237A5 JP 2004511237 A5 JP2004511237 A5 JP 2004511237A5 JP 2002534565 A JP2002534565 A JP 2002534565A JP 2002534565 A JP2002534565 A JP 2002534565A JP 2004511237 A5 JP2004511237 A5 JP 2004511237A5
- Authority
- JP
- Japan
- Prior art keywords
- reagent
- test
- screened
- molecules
- molecule
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US09/687,593 US6787321B1 (en) | 2000-10-13 | 2000-10-13 | Mammalian two-hybrid system for screening for modulators of the accumulation of metabolic products |
| PCT/US2001/031745 WO2002031201A2 (en) | 2000-10-13 | 2001-10-09 | Mammalian two-hybrid system for screening for modulators of the accumulation of metabolic products |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2004511237A JP2004511237A (ja) | 2004-04-15 |
| JP2004511237A5 true JP2004511237A5 (OSRAM) | 2009-01-29 |
Family
ID=24761035
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2002534565A Pending JP2004511237A (ja) | 2000-10-13 | 2001-10-09 | 代謝生成物の蓄積のモジュレーターについてスクリーニングするための哺乳動物２−ハイブリッドシステム |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US6787321B1 (OSRAM) |
| EP (1) | EP1327003B1 (OSRAM) |
| JP (1) | JP2004511237A (OSRAM) |
| AT (1) | ATE520788T1 (OSRAM) |
| AU (1) | AU2001296805A1 (OSRAM) |
| CA (1) | CA2424317A1 (OSRAM) |
| WO (1) | WO2002031201A2 (OSRAM) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2510179C (en) * | 2002-12-18 | 2013-04-23 | Chromagenics B.V. | A method for improving protein production |
| MX2007014221A (es) * | 2005-05-19 | 2009-02-17 | Wyeth Corp | Metodo para identificar compuestos que modulan la interaccion del receptor de androgeno con beta-catenina. |
| WO2008106087A1 (en) * | 2007-02-28 | 2008-09-04 | The Brigham And Women's Hospital, Inc. | Compositions and methods for identifying factors affecting protein stability |
| EP2500428A3 (en) | 2007-07-11 | 2012-12-26 | Yeda Research and Development Co. Ltd. | Nucleic acid construct systems capable of diagnosing or treating a cell state |
| WO2011019763A2 (en) * | 2009-08-10 | 2011-02-17 | The Board Of Trustees Of The University Of Illinois | Compositions and methods for the treatment of krabbe and other neurodegenerative diseases |
| WO2019099678A1 (en) | 2017-11-16 | 2019-05-23 | Synthex, Inc. | Selective modulation of protein-protein interactions |
| WO2020232343A1 (en) * | 2019-05-15 | 2020-11-19 | Synthex, Inc. | Selective degradation of proteins |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0370813A3 (en) | 1988-11-25 | 1991-06-19 | Exemplar Corporation | Rapid screening mutagenesis and teratogenesis assay |
| US5283173A (en) | 1990-01-24 | 1994-02-01 | The Research Foundation Of State University Of New York | System to detect protein-protein interactions |
| US5525490A (en) | 1994-03-29 | 1996-06-11 | Onyx Pharmaceuticals, Inc. | Reverse two-hybrid method |
| NZ502795A (en) | 1995-04-11 | 2001-09-28 | Gen Hospital Corp | Method of identifying molecular interactions employing counterselection and at least two hybrid molecules or two hybrid systems |
| FR2734567B1 (fr) | 1995-05-26 | 1997-08-08 | Commissariat Energie Atomique | Proteines chimeriques activant la transcription par la polymerase iii, leur utilisation pour la detection et l'analyse des interactions entre proteines, et genes codant pour lesdites proteines |
| USH1892H (en) | 1995-07-27 | 2000-10-03 | Pharmacia And Upjohn Company | High volume nutrient based yeast two-hybrid assay for the identification of specific protein:protein interacting inhibitors |
| US5948620A (en) | 1996-08-05 | 1999-09-07 | Amersham International Plc | Reverse two-hybrid system employing post-translation signal modulation |
| US6133027A (en) | 1996-08-07 | 2000-10-17 | City Of Hope | Inducible expression system |
| AU721549B2 (en) | 1996-12-11 | 2000-07-06 | Bristol-Myers Squibb Company | Prokaryotic two-hybrid system |
| US5851775A (en) * | 1997-03-20 | 1998-12-22 | Johns Hopkins University | β-catenin, Tcf-4, and APC interact to prevent cancer |
| US5885779A (en) * | 1997-09-09 | 1999-03-23 | University Of British Columbia | Repressed trans-activator system for characterization of protein-protein interactions |
| US6242253B1 (en) * | 1997-10-09 | 2001-06-05 | Regents Of The University Of California | IkB kinase, subunits thereof, and methods of using same |
-
2000
- 2000-10-13 US US09/687,593 patent/US6787321B1/en not_active Expired - Lifetime
-
2001
- 2001-10-09 WO PCT/US2001/031745 patent/WO2002031201A2/en not_active Ceased
- 2001-10-09 AT AT01977707T patent/ATE520788T1/de not_active IP Right Cessation
- 2001-10-09 EP EP01977707A patent/EP1327003B1/en not_active Expired - Lifetime
- 2001-10-09 JP JP2002534565A patent/JP2004511237A/ja active Pending
- 2001-10-09 CA CA002424317A patent/CA2424317A1/en not_active Abandoned
- 2001-10-09 AU AU2001296805A patent/AU2001296805A1/en not_active Abandoned
-
2004
- 2004-07-21 US US10/896,600 patent/US7358086B2/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE517125T1 (de) | ANTIKÖRPER GEGEN ßDEATH RECEPTOR 4ß (DR4) UND DEREN VERWENDUNGEN | |
| ATE444363T1 (de) | Il-21-antagonisten | |
| JP2005526147A5 (OSRAM) | ||
| JP2008513566A5 (OSRAM) | ||
| ATE451460T1 (de) | Antikörpermoleküle mit spezifizität für menschlichen tumornekrosefaktor-alpha, und deren verwendung | |
| DE122009000025I1 (de) | Antikörper gegen il-12, zusammensetzungen, verfahren und verwendungen | |
| JP2005520795A5 (OSRAM) | ||
| ATE541843T1 (de) | 2-acylamino-4-phenylthiazolderivate, ihre herstellung und anwendung als chemokin antagonisten | |
| BRPI0407755B1 (pt) | composiÇço catalÍtica, sua preparaÇço e uso | |
| JP2003520017A5 (OSRAM) | ||
| ATE437888T1 (de) | Aus chaperonin-polypeptiden gebildete geordnete biologische nanostrukturen | |
| JP2006517944A5 (OSRAM) | ||
| JP2002179603A5 (OSRAM) | ||
| ATE396745T1 (de) | Complex enthaltend modafinil und cyclodextrin | |
| ATE428706T1 (de) | Chemokinrezeptor-bindende heterocyclische verbindungen | |
| DE50002001D1 (de) | Anordnung zum verhältnisgleichen Ausbringen von zwei fliessfähigen Substanzen, insbesondere für Dentalzwecke | |
| DE60334012D1 (de) | Valerolactonverbindungen und parf mzusammensetzung | |
| JP2006505391A5 (OSRAM) | ||
| WO2005105842A3 (en) | Crystal structure of cytochrome p450 3a4 and uses thereof | |
| EP1630190A3 (en) | Polyhydrosiloxane compounds and articles and use thereof | |
| BR0208967B1 (pt) | Composto monoazocorante fibrorreativo, mistura deste, processos de formação do referido composto e da referida mistura e uso do corante fibrorreativo | |
| ATE467128T1 (de) | Kolloidale metallkonjugate | |
| JP2002358952A5 (OSRAM) | ||
| ATE339474T1 (de) | 1:2 metallkomplexfarbstoffe, deren zusammensetzungen, deren herstellung und deren verwendung | |
| TW200407408A (en) | Coating, process of preparation and use thereof on woody support |